Back to Search Start Over

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Authors :
Zamorano, JL
Lancellotti, P
Rodriguez Muñoz, D
Aboyans, V
Asteggiano, R
Galderisi, M
Habib, G
Lenihan, DJ
Lip, GY
Lyon, AR
Lopez Fernandez, T
Mohty, D
Piepoli, MF
Tamargo, J
Torbicki, A
Suter, TM
Achenbach, S
Agewall, S
Badimon, L
Barón-Esquivias, G
Baumgartner, H
Bax, JJ
Bueno, H
Carerj, S
Dean, V
Erol, Ç
Fitzsimons, D
Gaemperli, O
Kirchhof, P
Kolh, P
Nihoyannopoulos, P
Ponikowski, P
Roffi, M
Vaz Carneiro, A
Windecker, S
Authors/Task Force Members
ESC Committee for Practice Guidelines (CPG)
University of Zurich
Zamorano, Jose Luis
Centre Hospitalier Universitaire de Liège (CHU-Liège)
Neuroépidémiologie Tropicale (NET)
CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)
Università degli studi di Napoli Federico II
Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes (URMITE)
Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48
INSB-INSB-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48
INSB-INSB-Centre National de la Recherche Scientifique (CNRS)
British Heart Foundation
Action Against Cancer
Zamorano, Jose Lui
Lancellotti, Patrizio
Rodriguez Muñoz, Daniel
Aboyans, Victor
Asteggiano, Riccardo
Galderisi, Maurizio
Habib, Gilbert
Lenihan, Daniel J.
Lip, Gregory Y. H.
Lyon, Alexander R.
Lopez Fernandez, Teresa
Mohty, Dania
Piepoli, Massimo F.
Tamargo, Juan
Torbicki, Adam
Suter, Thomas M.
Achenbach, Stephan
Agewall, Stefan
Badimon, Lina
Barón Esquivias, Gonzalo
Baumgartner, Helmut
Bax, Jeroen J.
Bueno, Héctor
Carerj, Scipione
Dean, Veronica
Erol, Çetin
Fitzsimons, Donna
Gaemperli, Oliver
Kirchhof, Paulu
Kolh, Philippe
Nihoyannopoulos, Petro
Ponikowski, Piotr
Roffi, Marco
Vaz Carneiro, António
Windecker, Stephan
Lenihan, Daniel J
Lip, Gregory Y. H
Lyon, Alexander R
Piepoli, Massimo F
University of Naples Federico II = Università degli studi di Napoli Federico II
Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48
Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)
Source :
European Journal of Heart Failure, European Journal of Heart Failure, Oxford University Press (OUP), 2017, 19 (1), pp.9-42. ⟨10.1002/ejhf.654⟩, European Journal of Heart Failure, 2017, 19 (1), pp.9-42. ⟨10.1002/ejhf.654⟩
Publication Year :
2016

Abstract

2-D : two-dimensional 3-D : three-dimensional 5-FU : 5-fluorouracil ACE : angiotensin-converting enzyme ARB : angiotensin II receptor blocker ASE : American Society of Echocardiography BNP : B-type natriuretic peptide CABG : coronary artery bypass graft CAD : coronary artery

Subjects

Subjects :
Vascular Endothelial Growth Factor A
Angiotensin receptor
Cardiac & Cardiovascular Systems
cardio-oncology
medicine.medical_treatment
myocardial dysfunction
030204 cardiovascular system & hematology
ANTHRACYCLINE-INDUCED CARDIOMYOPATHY
chemotherapy
Coronary artery disease
0302 clinical medicine
RENAL-CELL CARCINOMA
Authors/Task Force Members
Cancer Survivors
Neoplasms
Natriuretic peptide
610 Medicine & health
early detection
ComputingMilieux_MISCELLANEOUS
Societies, Medical
HER2-POSITIVE BREAST-CANCER
TRASTUZUMAB-INDUCED CARDIOTOXICITY
Chemotherapy regimen
3. Good health
Europe
medicine.anatomical_structure
030220 oncology & carcinogenesis
CHEMOTHERAPY-INDUCED CARDIOTOXICITY
Practice Guidelines as Topic
cardiovascular system
Cardiology
surveillance
10209 Clinic for Cardiology
cancer therapy
CORONARY-ARTERY-DISEASE
ESC Committee for Practice Guidelines (CPG)
ischaemia
Immunotherapy
Cardiology and Cardiovascular Medicine
Life Sciences & Biomedicine
arrhythmias
Arrhythmia
Artery
Cardiovascular toxicity
medicine.medical_specialty
Heart Diseases
medicine.drug_class
Advisory Committees
Cancer therapy
Early detection
Antineoplastic Agents
[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery
1102 Cardiovascular Medicine And Haematology
2705 Cardiology and Cardiovascular Medicine
European Society of Cardiology
03 medical and health sciences
LEFT-VENTRICULAR DYSFUNCTION
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Internal medicine
medicine
TYROSINE KINASE INHIBITORS
Humans
cardiovascular diseases
Intensive care medicine
ACUTE LYMPHOBLASTIC-LEUKEMIA
Cardiotoxicity
Science & Technology
CONGESTIVE-HEART-FAILURE
Radiotherapy
business.industry
Arrhythmias
Cardio-oncology
Chemotherapy
Ischaemia
Myocardial dysfunction
Surveillance
Cancer
10181 Clinic for Nuclear Medicine
Congresses as Topic
medicine.disease
Radiation therapy
Cardiovascular System & Hematology
Cardiovascular System & Cardiology
Position paper
business
human activities
Document Reviewers

Details

ISSN :
15229645 and 13889842
Volume :
37
Issue :
36
Database :
OpenAIRE
Journal :
European heart journal
Accession number :
edsair.doi.dedup.....97072565cf70c85c5b780fdc245b8d7e